JP2008509084A5 - - Google Patents

Download PDF

Info

Publication number
JP2008509084A5
JP2008509084A5 JP2007513303A JP2007513303A JP2008509084A5 JP 2008509084 A5 JP2008509084 A5 JP 2008509084A5 JP 2007513303 A JP2007513303 A JP 2007513303A JP 2007513303 A JP2007513303 A JP 2007513303A JP 2008509084 A5 JP2008509084 A5 JP 2008509084A5
Authority
JP
Japan
Prior art keywords
epitope
activated
polypeptide
cells
pro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007513303A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008509084A (ja
JP5710854B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/016441 external-priority patent/WO2005110456A2/en
Publication of JP2008509084A publication Critical patent/JP2008509084A/ja
Publication of JP2008509084A5 publication Critical patent/JP2008509084A5/ja
Application granted granted Critical
Publication of JP5710854B2 publication Critical patent/JP5710854B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007513303A 2004-05-11 2005-05-11 Ｔ細胞死誘導エピトープ Expired - Fee Related JP5710854B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US57016104P 2004-05-11 2004-05-11
US60/570,161 2004-05-11
PCT/US2005/016441 WO2005110456A2 (en) 2004-05-11 2005-05-11 T-cell death-inducing epitopes

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012223627A Division JP2013049679A (ja) 2004-05-11 2012-10-05 Ｔ細胞死誘導エピトープ

Publications (3)

Publication Number Publication Date
JP2008509084A JP2008509084A (ja) 2008-03-27
JP2008509084A5 true JP2008509084A5 (enExample) 2008-06-26
JP5710854B2 JP5710854B2 (ja) 2015-04-30

Family

ID=35394670

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2007513303A Expired - Fee Related JP5710854B2 (ja) 2004-05-11 2005-05-11 Ｔ細胞死誘導エピトープ
JP2012223627A Pending JP2013049679A (ja) 2004-05-11 2012-10-05 Ｔ細胞死誘導エピトープ
JP2015093320A Expired - Fee Related JP6109234B2 (ja) 2004-05-11 2015-04-30 Ｔ細胞死誘導エピトープ

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2012223627A Pending JP2013049679A (ja) 2004-05-11 2012-10-05 Ｔ細胞死誘導エピトープ
JP2015093320A Expired - Fee Related JP6109234B2 (ja) 2004-05-11 2015-04-30 Ｔ細胞死誘導エピトープ

Country Status (20)

Country Link
US (3) US20060003940A1 (enExample)
EP (2) EP2450365A1 (enExample)
JP (3) JP5710854B2 (enExample)
KR (3) KR20130018989A (enExample)
CN (3) CN105777867A (enExample)
AR (1) AR048840A1 (enExample)
AU (1) AU2005244081B2 (enExample)
BR (1) BRPI0510561A (enExample)
CA (1) CA2565872C (enExample)
CL (1) CL2008003587A1 (enExample)
EC (1) ECSP067055A (enExample)
ES (1) ES2655833T3 (enExample)
IL (1) IL178837A (enExample)
MX (1) MXPA06012987A (enExample)
NO (1) NO20065648L (enExample)
NZ (3) NZ590478A (enExample)
RU (1) RU2412945C2 (enExample)
TW (3) TWI454274B (enExample)
UA (3) UA105492C2 (enExample)
WO (1) WO2005110456A2 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040116333A1 (en) * 2001-08-03 2004-06-17 Rong-Hwa Lin Modulators of P-selectin glycoprotein ligand 1
US7744888B2 (en) 2001-08-03 2010-06-29 Abgenomics Cooperatief U.A. Methods of modulating T cell or natural killer cell activity with anti-P-selectin glycoprotein ligand 1 antibodies
MY148646A (en) 2004-05-10 2013-05-15 Abgenomics Cooperatief Ua Anti-psgl-1 antibodies
BRPI0510561A (pt) 2004-05-11 2007-11-20 Abgenomics Corp epìtopos que induzem morte de célula t
WO2009093251A2 (en) * 2008-01-24 2009-07-30 Gavish-Galilee Bio Applications Ltd Reovirus vaccine based on sigma c protein sequence
EP2718325A4 (en) 2011-06-13 2015-03-11 ABGENOMICS COöPERATIEF U A ANTI-PSGL-1 ANTIBODIES AND USES THEREOF
WO2017120534A1 (en) 2016-01-08 2017-07-13 Bioalliance C.V. Tetravalent anti-psgl-1 antibodies and uses thereof
KR20250159733A (ko) 2017-01-11 2025-11-11 브리스톨-마이어스 스큅 컴퍼니 Psgl-1 길항제 및 그의 용도
PE20250933A1 (es) 2017-03-14 2025-04-02 Five Prime Therapeutics Inc Anticuerpos de union a vista a ph acido
SG11202008593PA (en) 2018-03-21 2020-10-29 Five Prime Therapeutics Inc ANTIBODIES BINDING TO VISTA AT ACIDIC pH
AU2019301120A1 (en) 2018-07-11 2021-02-25 Bristol-Myers Squibb Company Antibodies binding to VISTA at acidic pH

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
JPS61134325A (ja) * 1984-12-04 1986-06-21 Teijin Ltd ハイブリツド抗体遺伝子の発現方法
US5866363A (en) 1985-08-28 1999-02-02 Pieczenik; George Method and means for sorting and identifying biological information
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US4704692A (en) 1986-09-02 1987-11-03 Ladner Robert C Computer based system and method for determining and displaying possible chemical structures for converting double- or multiple-chain polypeptides to single-chain polypeptides
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US5378464A (en) * 1989-03-08 1995-01-03 Board Of Regents Of The University Of Oklahoma Modulation of inflammatory responses by administration of GMP-140 or antibody to GMP-140
US5464778A (en) * 1989-03-08 1995-11-07 Board Of Regents Of The University Of Oklahoma Glycoprotein ligand for P-selectin and methods of use thereof
US5690933A (en) * 1989-05-31 1997-11-25 Glaxo Wellcome Inc. Monoclonal antibodies for inducing tolerance
US5545806A (en) 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
ES2246502T3 (es) 1990-08-29 2006-02-16 Genpharm International, Inc. Animales no humanos transgenicos capaces de producir anticuerpos heterologos.
US5709859A (en) * 1991-01-24 1998-01-20 Bristol-Myers Squibb Company Mixed specificity fusion proteins
US6124267A (en) * 1991-02-05 2000-09-26 Southpac Trust Internationals, Inc. O-glycan inhibitors of selectin mediated inflammation derived from PSGL-1
US6309639B1 (en) * 1991-02-05 2001-10-30 The Board Of Regents Of The University Of Oklahoma Method for inhibiting an inflammatory response using antibodies to P-selectin glycoprotein ligand
US5972625A (en) * 1991-05-06 1999-10-26 The Regents Of The University Of California Assays for inhibitors of leukocyte adhesion
US5843707A (en) * 1992-10-23 1998-12-01 Genetics Institute, Inc. Nucleic acid encoding a novel P-selectin ligand protein
WO1994014836A1 (en) * 1992-12-18 1994-07-07 Centocor, Inc. Peptide inhibitors of selectin binding
DE69415154T2 (de) * 1993-01-25 1999-07-29 Dana-Farber Cancer Institute, Inc., Boston, Mass. Chimäre selektine erhältlich durch domänenaustauch und ihre verwendungen
WO1995014787A1 (en) * 1993-11-22 1995-06-01 Centocor, Inc. Peptide inhibitors of selecting binding
US6719972B1 (en) * 1994-06-03 2004-04-13 Repligen Corporation Methods of inhibiting T cell proliferation or IL-2 accumulation with CTLA4- specific antibodies
DE69630307T2 (de) 1995-08-03 2004-07-15 The Board Of Regents Of The University Of Oklahoma, Norman O-glycaninhibitoren von selectinvermittelten entzüngen
DE19629938C1 (de) 1996-07-24 1997-11-27 Gsf Forschungszentrum Umwelt E-Cadherin-Mutationen als Grundlage zur Diagnostik und Therapie humaner maligner Tumoren
US6048527A (en) * 1996-08-27 2000-04-11 Chiron Corporation Antibodies that define unique Meningococcal B epitopes and vaccine compositions
US5955259A (en) * 1996-12-19 1999-09-21 Brandeis University Method for assessing modulation of potassium ion channel activity
ES2284200T3 (es) * 1997-02-12 2007-11-01 Electrophoretics Limited Marcadores proteicos para cancer de pulmon y uso de los mismos.
US6551994B1 (en) 1997-04-10 2003-04-22 Mcgill University Compounds and methods for inhibiting the interaction between α-catenin and β-catenin
ATE480625T1 (de) 1997-11-21 2010-09-15 Merck Serono Biodevelopment Äusseres membranpolypeptid von chlamydia pneumoniae sowie fragmente davon und deren verwendung, insbesondere zur diagnose, prävention und behandlung einer infektion
WO1999043353A2 (en) * 1998-02-26 1999-09-02 Boehringer Ingelheim Pharmaceuticals, Inc. Combination anti-selectin and immunosuppressant therapy
CN1342085A (zh) 1998-10-30 2002-03-27 遗传研究所有限公司 通过p－选择素配体(psgl)拮抗剂抑制细胞素t细胞的分化
DE19925199A1 (de) * 1999-06-01 2000-12-07 Medigene Ag Zytotoxische T-Zellepitope des Papillomavirus L1-Proteins und ihre Verwendung in Diagnostik und Therapie
WO2001079555A2 (en) * 2000-04-14 2001-10-25 Millennium Pharmaceuticals, Inc. Roles of jak/stat family members in tolerance induction
WO2002022820A1 (en) * 2000-09-12 2002-03-21 Genetics Institute, Llc Inhibition of stenosis or restenosis by p-selectin antagonists
US20040001839A1 (en) * 2000-12-29 2004-01-01 Avigdor Levanon Multimers - isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof
PL366223A1 (en) * 2000-12-29 2005-01-24 Bio-Technology General Corp. Isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof
US20040002450A1 (en) * 2000-12-29 2004-01-01 Janette Lazarovits Y17 - isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof
NZ512341A (en) * 2001-06-13 2004-02-27 Bayer Ag Polynucleotides between 15 and 100 base pairs in length coding for parapoxvirus ovis (PPVO)/vaccinia virus recombinant (VVOV) viral genome fragments
US7744888B2 (en) * 2001-08-03 2010-06-29 Abgenomics Cooperatief U.A. Methods of modulating T cell or natural killer cell activity with anti-P-selectin glycoprotein ligand 1 antibodies
US20040116333A1 (en) * 2001-08-03 2004-06-17 Rong-Hwa Lin Modulators of P-selectin glycoprotein ligand 1
US20030130174A1 (en) * 2001-10-19 2003-07-10 Cummings Richard D. Glycosulfopeptide inhibitors of leukocyte rolling and methods of use thereof
AU2003263764A1 (en) * 2002-07-01 2004-01-19 Savient Pharmaceuticals, Inc. Antibodies and uses thereof
US20040213766A1 (en) * 2002-11-27 2004-10-28 Cedric Francois Compositions and methods for treating transplants
US20050152906A1 (en) * 2003-06-30 2005-07-14 Avigdor Levanon Specific human antibodies
EP1663290A4 (en) * 2003-09-15 2009-07-01 Abgenomics Corp MODULATORS OF P-SELECTIN GLYCOPROTEIN LIGANDS 1
MY148646A (en) * 2004-05-10 2013-05-15 Abgenomics Cooperatief Ua Anti-psgl-1 antibodies
BRPI0510561A (pt) 2004-05-11 2007-11-20 Abgenomics Corp epìtopos que induzem morte de célula t
EP2718325A4 (en) 2011-06-13 2015-03-11 ABGENOMICS COöPERATIEF U A ANTI-PSGL-1 ANTIBODIES AND USES THEREOF

Similar Documents

Publication Publication Date Title
JP2013512889A5 (enExample)
JP2020517628A5 (enExample)
IL195338A (en) An antibody comprising an FC variant containing amino acid replaces d or e at position 239, a medicament containing it and its use
TWI772257B (zh) 抗體介導屈公（ｃｈｉｋｕｎｇｕｎｙａ）病毒中和
EP2287201A3 (en) RS7 antibodies
NO20010412L (no) Anvendelse av borreliacidal(e) epitoper av Borrelia burgdorferi ytre overflateprotein C som vaksine
JP2004510439A5 (enExample)
CA2253374C (en) Novel osp-c derived peptide fragments
JP2009529497A5 (enExample)
Peng et al. Mosquito salivary allergen Aed a 3: cloning, comprehensive molecular analysis, and clinical evaluation
RU2006143689A (ru) Эпитопы, индуцирующие гибель т-клеток
JP2015513314A5 (enExample)
McMillan et al. Identification and assessment of new vaccine candidates for group A streptococcal infections
EP0463059A1 (en) Allergenic proteins from ragweed and uses therefor
JP2008516985A5 (enExample)
NO950526D0 (no) T-celleepitoper av raigresspollen-allergen
JP2004502782A5 (enExample)
JP2005502324A5 (enExample)
AU2002242273B2 (en) Compositions of multimeric profilin for diagnosis and treatment of allergies
JP2008522632A5 (enExample)
Gupta et al. Immune response against M protein-conserved region peptides from prevalent group A Streptococcus in a North Indian population
JP2008509659A5 (enExample)
Gomme et al. Evaluation of a pepscan approach to identify epitopes recognised by anti-hTSH monoclonal antibodies
JP2008512391A5 (enExample)
JP2005536220A5 (enExample)